-
NHG-werkgroep DVT en LE. NHG-Standaard Diepe veneuze trombose en longembolie (tweede partiële herziening). Huisarts Wet 2017;60:460.
-
van den Donk M, de Jong J, Geersing G-J, et al. NHG-Standpunt Anticoagulantia - Cumarinederivaten en DOAC’s voortaan gelijkwaardig. Huisarts Wet 2016;59:406-409.
-
Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016;37:2893-2962.
-
Nederlandse Internisten Vereniging (NIV). Richtlijn Antitrombotisch beleid. 2016.
-
Virchow R. Gesammelte Abhandlungen Zur Wissenschaftlichen Medicin. Frankfurt A.M.: Verlag von Meidinger Rosh & Comp., 1856.
-
Riedel M. Acute pulmonary embolism 1: pathophysiology, clinical presentation, and diagnosis. Heart 2001;85:229-240.
-
van Weert H, Dolan G, Wichers I, et al. Spontaneous superficial venous thrombophlebitis: does it increase risk for thromboembolism? A historic follow-up study in primary care. J Fam Pract 2006;55:52-57.
-
Stein PD, Beemath A, Matta F, et al. Clinical Characteristics of Patients with Acute Pulmonary Embolism. Am J Med 2007;120:871-879.
-
Schiff GD, Hasan O, Kim S, et al. Diagnostic error in medicine: analysis of 583 physician-reported errors. Arch Intern Med 2009;169:1881-1887.
-
Cohen AT, Agnelli G, Anderson FA, et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007;98:756-764.
-
Henriksen J, Koster-Van Ree M, Morgenstern M, et al. Diagnostische vertraging bij longembolie. Huisarts Wet 2018;61:29-32.
-
Lepic K, Naassan AE, Crowther MA. The Inappropriate Use of the SimpliRed D-Dimer Assay in the Diagnosis of Venous Thromboembolism,. Blood 2011;118:4207-4207.
-
Hendriksen JMT, Geersing G-J, van Voorthuizen SC, et al. The cost-effectiveness of point-of-care D-dimer tests compared with a laboratory test to rule out deep venous thrombosis in primary care. Expert Rev Mol Diagn 2015;15:125-136.
-
Bertsch T, Chapelle J-P, Dempfle C-E, et al. Multicentre analytical evaluation of a new point-of-care system for the determination of cardiac and thromboembolic markers. Clin Lab 2010;56:37-49.
-
van der Hulle T, Cheung WY, Kooij S, et al. Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study. Lancet 2017;390:289-297.
-
van der Pol LM, Tromeur C, Bistervels IM, et al. Pregnancy-Adapted YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism. N Engl J Med 2019;380:1139-1149.
-
Kearon C. Natural history of venous thromboembolism. Circulation 2003;107:I22-30.
-
Brandjes DP, Büller HR, Heijboer H, et al. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 1997;349:759-762.
-
Boot-Bloemen M, Van Ruth S. Compressietherapie ter preventie van posttrombotisch syndroom na een diepe veneuze trombose. Ned Tijdschr VOOR Dermatol EN Venereol 2016;26:63-68.
-
Ten Cate-Hoek AJ. Diagnose en preventie van het posttrombotisch syndroom. Ned Tijdschr Voor Hematol 2018;15:319-325.
-
Ten Cate-Hoek AJ, Amin EE, Bouman AC, et al. Individualised versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome (IDEAL DVT): a multicentre, randomised, single-blind, allocation-concealed, non-inferiority trial. Lancet Haematol 2018;5:e25-e33.
-
-
Walma E, Eekhof J, Nikkels J, et al. NHG-Standaard Varices | NHG. 2009;52:391-402.
-
Leizorovicz A, Becker F, Buchmüller A, et al. Clinical relevance of symptomatic superficial-vein thrombosis extension: lessons from the CALISTO study. Blood 2013;122:1724-1729.
-
Beyer-Westendorf J, Schellong SM, Gerlach H, et al. Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial. Lancet Haematol 2017;4:e105-e113.
-
-
Connolly SJ, Crowther M, Eikelboom JW, et al. Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors. N Engl J Med 2019;380:1326-1335.
-
-
-
-
-
-
-
Pengo V, Denas G, Zoppellaro G, et al. Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome. Blood 2018;132:1365-1371.
-
-
-
Rennenberg RJMW, van Varik BJ, Schurgers LJ, et al. Chronic coumarin treatment is associated with increased extracoronary arterial calcification in humans. Blood 2010;115:5121-5123.
-
Hasific S, Oevrehus KA, Gerke O, et al. Risk of arterial calcification by conventional vitamin K antagonist treatment. Eur Heart J 2019;40.
-
Rennenberg R. Vascular calcifications and matrix Gla protein in hypertensive subjects. Datawyse/Universitaire Pers Maastricht. January 2011.
-
UMC st Radboud, NCEF, CWZ, et al. Regionale Richtlijn Non-VKA Orale Anticoagulantia (NOAC) Directe Orale Anticoagulantia (DOAC). 2018.
-
-
Kelman CW, Kortt MA, Becker NG, et al. Deep vein thrombosis and air travel: record linkage study. BMJ 2003;327:1072.
-
-
Gool, V, De Vries H, Bons S, et al. Gewichtsverlies. Huisarts Wet 2009;46:39-42.
-
-
Account
1
